Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment

Med Oncol. 2022 May 17;39(7):108. doi: 10.1007/s12032-022-01680-5.

Abstract

Chronic inflammation and immune response are two central hallmarks of the tumor microenvironment (TME), teeming with immune cells and inflammatory cytokines that promote tumor progression. Intriguingly, there is mutual regulation between immune cells and cytokines. Indeed, the differentiation and function of immune cells depend on cytokines secreted from tumor cells, whereas immune activation affects the dynamics of cytokines, reshaping the TME together. Long non-coding RNAs (lncRNAs) as a blooming molecule are virtually involved in physiology and pathology events, especially TME. Notably, the regulatory loop between lncRNAs and cytokines or immune activation plays a vital role in tumor growth. Thus, this review concentrates on the interaction between lncRNAs and immune cells. It puts special attention to the intertwist between lncRNAs and cytokines or immune cells, providing a theoretical basis for lncRNAs as a potential biomarker and therapeutic tumor target.

Keywords: Chronic inflammation; Cytokines; Immune cells; Long non-coding RNA; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Cytokines
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • RNA, Long Noncoding* / genetics
  • Tumor Microenvironment

Substances

  • Cytokines
  • RNA, Long Noncoding